mRNA cancer immunotherapy

Latest Post

Hibsago (Bepirovirsen): Key Trends and Developments in Chronic Hepatitis B Treatment FDA Hosts Webinar on ICH M15 Guidance for Model-Informed Drug Development Baby Memorial Hospital Group Partners With DeepInfinity.AI to Scale Clinical AI Molecular Partners Plans 44% Workforce Reduction to Focus on Radiotherapeutics Geron Discontinues Phase III Myelofibrosis Trial After Survival Goal Setback

BioNTech mRNA Cancer Therapy Trial: BNT113 Misses PFS Goal

October 13, 2026 Simone Lamb

BioNTech mRNA cancer therapy trial: BNT113 missed the PFS endpoint in AHEAD-MERIT, but the study continues to an overall survival analysis.

You missed

Hibsago (Bepirovirsen): Key Trends and Developments in Chronic Hepatitis B Treatment

October 30, 2026 Simone Lamb

FDA Hosts Webinar on ICH M15 Guidance for Model-Informed Drug Development

October 30, 2026 Simone Lamb

Baby Memorial Hospital Group Partners With DeepInfinity.AI to Scale Clinical AI

October 30, 2026 Simone Lamb

Molecular Partners Plans 44% Workforce Reduction to Focus on Radiotherapeutics

October 30, 2026 Simone Lamb